Share Prices & Company Research

Stockbroking

Alliance Pharma

Current Price 77.90p Bid 77.90p Ask 78.60p Change -1.14%
Last Updated: 18/04/2019 17:20. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Alliance Pharma plc is an international speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Group has sales in more than 100 countries worldwide via direct sales, joint ventures and a network of distributors. Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Group continues to explore opportunities to expand its product portfolio.

Financial Highlights Year Ended 31/12/2018

Turnover
£118.21m
Operating Profit
£23.67m
Dividend Yield
1.85
Dividend Per Share
1.46
Dividend Cover
2.52
P/E Ratio
21.41

Key Personnel

Peter Jonathan Butterfield
Chief Executive Officer
Andrew Timothy Franklin
Finance Director
David John Cook
Non-Executive Chairman
Joanna Susan Le Couilliard
Non-Executive Director
Richard Crispin Morgan Jones
Non-Executive Director
John Dawson
Non-Executive Director
Nigel Richard Clifford
Non-Executive Director

Stock Details

EPIC
APH
ISIN
GB0031030819
Shares in Issue
518,230,255
Market cap
£409.40m

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
77.90p
Bid Price
77.90p
Ask Price
78.60p
Volume
1192754
Change Today
-0.90p
% Change Today
-1.14%
Open
77.40p
Previous Close
77.90p
Intraday High
81.00p
Intraday Low
75.00p
52 Week High
102.50p
52 Week Low
59.20p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Alliance Pharma Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Tangible Assets
7.6
3.4
Intangible Assets & Goodwill
335.2
278.6
Investments & Other Non-Current Assets
2.0
5.4
Total Non-Current Assets
344.9
287.4
Inventory
18.7
14.3
Trade & Receivables
29.2
23.7
Cash & Receivables
10.9
11.2
Other Current Assets & Assets Held for Resale
0.0
0.0
Total Assets
403.6
336.5

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Short Term Liabilities
91.7
60.8
Long Term Liabilities
59.7
72.3
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
151.4
133.1

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Net Assets
252.2
203.4

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Share Capital
5.2
4.8
Minority Interests
0.0
0.0
Retained Earnings
95.1
83.4
Share Premium Account
144.6
110.3
Other Equity
7.3
5.0
Total Equity
252.2
203.4

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Cashflow from Operating Activities
22.2
26.6
Cashflow Before Financing
-36.9
10.7
Increase / Decrease in Cash
-0.3
4.2

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Turnover
118.2
103.3
Cost of Sales
45.6
44.4
Gross Profit
72.7
59.0
Operating Profit
23.7
30.2
Pre-Tax Profit
22.8
28.4
Profit / Loss for the Year
18.4
28.9

Dividend History

Data has been provided by AJ Bell

Period
Ex-Dividend Date
Payment Date
H2 Dividend
13 Jun 2019
11 Jul 2019
H1 Dividend
20 Dec 2018
10 Jan 2019
H2 Dividend
14 Jun 2018
11 Jul 2018
H1 Dividend
21 Dec 2017
11 Jan 2018
H2 Dividend
15 Jun 2017
12 Jul 2017
H1 Dividend
22 Dec 2016
12 Jan 2017
H2 Dividend
16 Jun 2016
13 Jul 2016
H1 Dividend
24 Dec 2015
14 Jan 2016
H2 Dividend
18 Jun 2015
15 Jul 2015
H1 Dividend
04 Dec 2014
15 Jan 2015
H2 Dividend
11 Jun 2014
10 Jul 2014
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.